Boten increased cdmo capacity construction of API
In order to meet the rapidly growing business demand, Chongqing Boteng Pharmaceutical Technology Co., Ltd. today announced an investment of 260 million yuan to expand the API cdmo capacity located in Chongqing Changshou production base. The expansion project is workshop 301 of Changshou production base, which is positioned as a medium-sized commercial GMP intermediate flexible production capacity. The project is expected to be put into operation in March 2023. After the project is put into operation, the total capacity of Changshou production base will be 900m ³ Increase the production capacity by 16%.
This text is a result of machine translation.
Related companies：
In-depth
Consumer Staples, Technology
Smart IoT Device Brings Future Homes into Focus, but Sparks with Interoperability Issue
With the dawn of home automation having been heralded for years, the 'smart' label of in-home products as forthcoming additions has become ubiquitous in the sustainable technology market. Global companies sought to further underline their credentials in home automation which led to a massive stretch of the imagination from smart light bulbs and thermostats to doorbells.
Jun 02, 2022 10:07 PM
Briefing Jun 28, 2022 01:54 PM
· Financials
Suspension of large amount subscription of Jingshun great wall reform opportunity hybrid fund
Dec 28, 2021 06:19 PM
Jun 29, 2021 11:48 PM
Jan 03, 2021 10:56 AM
Nov 06, 2020 10:00 AM
Briefing Jun 27, 2022 12:35 PM
· Automotive
According to the German business daily, Mercedes Benz will stop manufacturing class a cars around 2025.
Briefing Jun 27, 2022 12:14 PM
· Communication
Tencent QQ responded to large-scale account theft: the affected area has been controlled and criminal evidence of Mafia gangs is being collected
See more
Read next
Insight
In-depth
Insight
In-depth